Intracellular Signaling of Cardiac Fibroblasts
- 16 March 2015
- book chapter
- Published by Wiley
- Vol. 5 (2) , 721-760
Abstract
Long regarded as a mere accessory cell for the cardiomyocyte, the cardiac fibroblast is now recognized as a critical determinant of cardiac function in health and disease. A recent renaissance in fibroblast‐centered research has fostered a better understanding than ever before of the biology of fibroblasts and their contractile counterparts, myofibroblasts. While advanced methodological approaches, including transgenics, lineage fate mapping, and improved cell marker identification have helped to facilitate this new work, the primary driver is arguably the contribution of myofibroblasts to cardiac pathophysiology including fibrosis and arrhythmogenesis. Fibrosis is a natural sequel to numerous common cardiac pathologies including myocardial infarction and hypertension, and typically exacerbates cardiovascular disease and progression to heart failure, yet no therapies currently exist to specifically target fibrosis. The regulatory processes and intracellular signaling pathways governing fibroblast and myofibroblast behavior thus represent important points of inquiry for the development of antifibrotic treatments. While steady progress is being made in uncovering the signaling pathways specific for cardiac fibroblast function (including proliferation, phenotype conversion, and matrix synthesis), much of what is currently known of fibroblast signaling mechanisms is derived from noncardiac fibroblast populations. Given the heterogeneity of fibroblasts across tissues, this dearth of information further underscores the need for progress in cardiac fibroblast biological research. © 2015 American Physiological Society.Compr Physiol5:721‐760, 2015.Keywords
This publication has 573 references indexed in Scilit:
- 5-Lipoxygenase facilitates healing after myocardial infarctionBasic Research in Cardiology, 2013
- MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heartAGE, 2012
- Actin Filament Elasticity and Retrograde Flow Shape the Force-Velocity Relation of Motile CellsBiophysical Journal, 2012
- Proteomic analysis identifies in vivo candidate matrix metalloproteinase‐9 substrates in the left ventricle post‐myocardial infarctionProteomics, 2010
- Control of cell adhesion dynamics by Rap1 signalingCurrent Opinion in Cell Biology, 2009
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2008
- Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblastsBiochemical and Biophysical Research Communications, 2007
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130CasCell, 2006
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993